Table 1 summarizes the ED caused by purinergic receptors activation or inhibition, and Fig. 1 summarizes the role of purinergic receptors in atherosclerosis via their regulation of vascular tone, inflammation, and platelet aggregation. This evidence concerns the gene P2RY1 and atherosclerosis.